Skip to main content
Log in

Locally Recurrent Rectal Cancer: Prognostic Factors and Long-Term Outcomes of Multimodal Therapy

  • Colorectal Cancer
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Pelvic recurrent rectal cancer is still a challenging clinical problem, and patients generally have a dismal prognosis and a poor quality of life. Surgical resection represents the only potentially curative treatment; neoadjuvant treatments are presently being taken into consideration to increase the resectability rate and to improve long-term survival.

Methods

Among 157 patients observed with recurrent rectal cancer, a series of 58 patients who underwent surgical exploration with curative intent for isolated local recurrence at a single referral institution was retrospectively analyzed. Demographic, pathologic, and therapeutic factors were evaluated to assess long-term prognosis and local control.

Results

Forty-four (75.9%) of 58 patients underwent surgical resection. The overall 5-year survival rate for patients who underwent surgical resection was 54.2%, whereas none of the unresected patients lived 5 years (P < 0.001). Patients with R0 resection showed a statistically higher 5-year overall survival and local control rate (72.4 and 70.2%, respectively) compared to R1 patients (37.5 and 31.2%, respectively). At multivariate survival analysis, feasibility of a surgical resection and radicality of excision proved to be independent positive prognostic factors. In contrast, increased presalvage carcinoembryonic antigen serum levels, back pain at diagnosis, and an increasing degree of fixation of recurrent disease to the pelvic wall at preoperative computed tomographic scan were statistically significantly linked to decreased overall survival. Preoperative chemoradiation and radicality of the surgical excision independently influenced the local control among surgically resected patients.

Conclusions

Surgical resection still remains the most important therapeutic and prognostic factor for patients with locally recurrent rectal cancer. Multimodal treatments can be safely performed by an experienced team in referral tertiary centers and can result in a safer outcome, better local disease control, and even long-term survival in carefully selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in respectable rectal cancer. N Engl J Med. 1997;336:980–7.

    Article  Google Scholar 

  2. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46.

    Article  CAS  PubMed  Google Scholar 

  3. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.

    Article  CAS  PubMed  Google Scholar 

  4. Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg. 2003;237:502–4.

    Article  PubMed  Google Scholar 

  5. Heald RJ, Moran BJ, Ryall RDH, et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133:894–9.

    Article  CAS  PubMed  Google Scholar 

  6. Pacelli F, Di Giorgio A, Papa V, et al. Preoperative radiotherapy combined with intraoperative radiotherapy improve results of total mesorectal excision in patients with T3 rectal cancer. Dis Colon Rectum. 2004;47:170–9.

    Article  PubMed  Google Scholar 

  7. Mannaerts GHH, Rutten HJT, Martijn H, et al. Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon Rectum. 2001;44:1749–58.

    Article  CAS  PubMed  Google Scholar 

  8. Boyle KM, Sagar PM, Chalmers AG, et al. Surgery for locally recurrent rectal cancer. Dis Colon Rectum 2005;48:929–37.

    Article  PubMed  Google Scholar 

  9. Suzuki K, Dozois RR, Devine RM, et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum. 1996;39:730–6.

    Article  CAS  PubMed  Google Scholar 

  10. Valentini V, Morganti AG, De Franco A, et al. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome. Cancer. 1999;86:2612–24.

    Article  CAS  PubMed  Google Scholar 

  11. Mohiuddin M, Marks GM, Lingareddy V, et al. Curative surgical resection following reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1997;40:150–5.

    Google Scholar 

  12. Hashiguchi Y, Sekine T, Sakamoto H, et al. Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum. 1999;42:886–95.

    Article  CAS  PubMed  Google Scholar 

  13. Suzuki K, Gunderson LL, Devine RM, et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer. 1995;75:939–52.

    Article  CAS  PubMed  Google Scholar 

  14. Pilipshen SJ, Heiweil M, Quan SHQ, et al. Patterns of pelvic recurrence following definitive resection of rectal cancer. Cancer. 1984;53:1354–62.

    Article  CAS  PubMed  Google Scholar 

  15. De Franco A, Vecchioli Scaldazza A, Celi G. Stadiazione mediante imaging delle recidive locali da neoplasia del retto. In: Basilico L, Valentini V, eds. Le recidive pelviche da neoplasia del retto. Diagnosi Stadiazione e Terapia. Vasto: Arte della Stampa-Cannarsa, 1998:36–41.

    Google Scholar 

  16. Radice E, Dozois RR. Locally recurrent rectal cancer. Dig Surg 2001;18:355–62.

    Article  CAS  PubMed  Google Scholar 

  17. Palmer G, Martling A, Cedermark B, et al. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2006;15:3109–17.

    Article  Google Scholar 

  18. Dresen RC, Gosens MJ, Martijn H, et al. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol. 2008;15:1937–47.

    Article  PubMed  Google Scholar 

  19. Salo JC, Paty PB, Guillem J, et al. Surgical salvage of recurrent rectal carcinoma after curative resection: a ten-year experience. Ann Surg Oncol. 1999;6:171–7.

    Article  CAS  PubMed  Google Scholar 

  20. Wiig JN, Tveit KM, Poulsen JP, et al. Preoperative irradiation andsurgery for recurrent rectal cancer. Will inntraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol. 2002;62:207–13.

    Article  PubMed  Google Scholar 

  21. Caricato M, Borzomati D, Ausania F, et al. Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol. 2006;32:126–32.

    Article  CAS  PubMed  Google Scholar 

  22. Vermaas M, Nuyttens JJME, Ferenschild FTJ, et al. Reirradiation, surgery and IORT for recurrent rectal cancer in previously irradiated patients. Radiother Oncol. 2008;87:357–60.

    Article  PubMed  Google Scholar 

  23. Miller AR. Multidisciplinary management of recurrent colorectal cancer. Surg Oncol. 1998;7:209–21.

    Article  CAS  PubMed  Google Scholar 

  24. Valentini V, Morganti AG, Gambacorta MA, et al. Preoperative hyperfractioned chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study. Int J Radiat Oncol Biol Phys. 2006;64:1129–39.

    PubMed  Google Scholar 

  25. Haddock MG, Gunderson L, Nelson H, et al. Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients. Int J Radiat Oncol Biol Phys. 2001;49:1267–74.

    CAS  PubMed  Google Scholar 

  26. Glimelius B. Recurrent rectal cancer. The pre-irradiated primary tumour: can more radiotherapy be given? Colorectal Dis. 2003;5:501–3.

    Article  PubMed  Google Scholar 

  27. Wanebo HJ, Koness RJ, Vezeridis MP, et al. Pelvic resection of recurrent rectal cancer. Ann Surg. 1994;220:586–97.

    Article  CAS  PubMed  Google Scholar 

  28. Lopez-Koster F, Fazio VW, Vignali A, et al. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum. 2001;44:173–8.

    Article  Google Scholar 

  29. Nagtegaal ID, van de Velde CJ, Marijnen CA, et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23:9257–64.

    Article  PubMed  Google Scholar 

  30. West NP, Finan PJ, Anderin C, et al. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol. 2008;26:3517–22.

    Article  PubMed  Google Scholar 

  31. Holm T, Ljung A, Häggmark T, et al. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg. 2007;94:232–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

We thank Dr. M. A. Gambacorta for her assistance on oncological data and Dr. G. La Torre, Dr. N. Nicolotti, and Dr. M. Covino for their suggestions for the statistical analyses.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fabio Pacelli MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pacelli, F., Tortorelli, A.P., Rosa, F. et al. Locally Recurrent Rectal Cancer: Prognostic Factors and Long-Term Outcomes of Multimodal Therapy. Ann Surg Oncol 17, 152–162 (2010). https://doi.org/10.1245/s10434-009-0737-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-009-0737-5

Keywords

Navigation